2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
203 000 patients have now been treated<br />
An increase of 88% versus December 2009<br />
<strong>UCB</strong> is becoming the<br />
Patient-Centric global biopharmaceutical leader<br />
Fast response for predictable outcomes<br />
22 000 patients prescribed<br />
Expected peak sales of at least € 1.5 billion 1<br />
When monotherapy is no longer enough<br />
108 000 patients prescribed<br />
Expected peak sales of at least € 1.2 billion 1<br />
24h continuous delivery by transdermal patch<br />
73 000 patients prescribed<br />
Expected peak sales of at least € 400 million 1<br />
1 to be reached in the second half of the decade<br />
5
Change language